In addition, SRPK1 is involved in the progression of many types of cancer, including breast cancer, prostate cancer, lung cancer, and melanoma, and the expression of its downstream targets are reported to be increased significantly [10–14]. This evidence concerns the gene SRPK1 and breast carcinoma.